Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quinn, J.
Right arrow Articles by Kaye, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quinn, J.
Right arrow Articles by Kaye, J. A.
Related Collections
Right arrow All Cognitive Disorders/Dementia
Neurology 2002;58:433-437
© 2002 American Academy of Neurology

A videotaped CIBIC for dementia patients

Validity and reliability in a simulated clinical trial J. Quinn, MD, M. Moore, BS, D. F. Benson, MD{dagger}, C. M. Clark, MD, R. Doody, MD PhD;, W. Jagust, MD, D. Knopman, MD and J. A. Kaye, MD

{dagger}Deceased.
From the Departments of Neurology, the Portland Veteran’s Affairs Medical Center (Drs. Quinn and Kaye) and Oregon Health Sciences University (Drs. Quinn, Kaye, Benson, and M. Moore); Department of Neurology (Dr. Clark), University of Pennsylvania, Philadelphia; Department of Neurology (Dr. Doody), Baylor College of Medicine, Houston, TX; Department of Neurology (Dr. Jagust), University of California at Davis; and Department of Neurology (Dr. Knopman), Mayo Clinic, Rochester, MN.

Address correspondence and reprint requests to Dr. Joseph Quinn, Portland Veteran’s Affairs Medical Center, P3 R&D, 3710 SW US Veteran’s Hospital Road, Portland, OR 97201; e-mail: quinnj{at}ohsu.edu

Background: The global impression of a clinician is an Food and Drug Administration–mandated primary outcome measure for clinical trials in dementia. Reliability and validity of these measures are not well established.

Methods: A videotaped version of the Clinician’s Interview Based Impression of Change (CIBIC) was evaluated. Raters were informed that the videotaped interviews were taken at baseline and 6 to 12 months later, when in fact half of the interviews were shown in reverse order. Ratings on "true order" interviews were compared with ratings on "reverse order" interviews. In addition, ratings by neurologists experienced in dementia were compared with those of less experienced raters.

Results: Inter-rater reliability of the neurologists was poor when measured by absolute agreement on a 7-point scale (kappa = 0.18). With a less stringent 3-point scale (better, worse, or unchanged), inter-rater reliability was significantly better for the true order videos (kappa = 0.51) than for the reversed order videos (kappa = 0.12). Validity also was reduced in the reverse order group: neurologists rated 90% of subjects correctly in the "true order" group and 63% correctly in the "reversed order" group. The inter-rater reliability of the neurologists was greater than the less experienced raters, but the validity of the neurologists’ ratings was only marginally better.

Conclusions: The reliability and validity of the videotape CIBIC are reasonable when patients follow the expected course of gradual decline, but are poor when patients appear to improve. These findings suggest that global assessments should be modified as outcome measures in clinical trials with patients with dementia.




This article has been cited by other articles:


Home page
NeurologyHome page
S. E. Black, R. Doody, H. Li, T. McRae, K. M. Jambor, Y. Xu, Y. Sun, C. A. Perdomo, and S. Richardson
Donepezil preserves cognition and global function in patients with severe Alzheimer disease
Neurology, July 31, 2007; 69(5): 459 - 469.
[Abstract] [Full Text] [PDF]


Home page
Adv. Psychiatr. Treat.Home page
J. Warner
Clinicians' guide to evaluating diagnostic and screening tests in psychiatry
Adv. Psychiatr. Treat., November 1, 2004; 10(6): 446 - 454.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
K Rockwood
Size of the treatment effect on cognition of cholinesterase inhibition in Alzheimer's disease
J. Neurol. Neurosurg. Psychiatry, May 1, 2004; 75(5): 677 - 685.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. Erkinjuntti, G. Roman, S. Gauthier, H. Feldman, and K. Rockwood
Emerging Therapies for Vascular Dementia and Vascular Cognitive Impairment
Stroke, April 1, 2004; 35(4): 1010 - 1017.
[Abstract] [Full Text] [PDF]